Duo Oncology Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $8M

  • Investors
  • 10

Duo Oncology General Information

Description

Developer of nanoparticle technology intended to redefine the treatment landscape for patients with pancreatic cancer and other hard-to-treat tumors. The company's technology specializes in transforming outcomes with a new type of monotherapy to improve the care for patients with pancreatic cancer, bile duct cancer, and relapsed metastatic disease, compelling data, addresses indications in immunotherapy and precision medicine, thereby enabling patients to recover at a fast speed and efficiency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4165 Blair Street
  • Pittsburgh, PA 15207
  • United States
+1 (412)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Vertical(s)
Nanotechnology, HealthTech, Oncology
Corporate Office
  • 4165 Blair Street
  • Pittsburgh, PA 15207
  • United States
+1 (412)

Duo Oncology Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Duo Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series A) $8M Completed Pre-Clinical Trials
5. Accelerator/Incubator 21-Mar-2024 Completed Pre-Clinical Trials
4. Accelerator/Incubator Completed Pre-Clinical Trials
3. Grant 27-Oct-2023 Completed Pre-Clinical Trials
2. Seed Round 11-Aug-2023 $4.25M $4.25M Completed Pre-Clinical Trials
1. Accelerator/Incubator 03-Nov-2020 Completed Pre-Clinical Trials
To view Duo Oncology’s complete valuation and funding history, request access »

Duo Oncology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
Seed-1
To view Duo Oncology’s complete cap table history, request access »

Duo Oncology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of nanoparticle technology intended to redefine the treatment landscape for patients with pancreatic cancer an
Discovery Tools (Healthcare)
Pittsburgh, PA
4 As of 2024

Austin, TX
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Duo Oncology Competitors (47)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genprex Formerly VC-backed Austin, TX
MiNA Therapeutics Venture Capital-Backed London, United Kingdom
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands
CytImmune Sciences Private Equity-Backed Rockville, MD
Innocare Formerly VC-backed Beijing, China
You’re viewing 5 of 47 competitors. Get the full list »

Duo Oncology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Duo Oncology Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Cancer Institute I-Corps Accelerator/Incubator
U.S. Department of Health and Human Services Government
BeiGene Corporation Minority
Innovation Works Venture Capital Minority
NuFund Venture Group Angel Group Minority
You’re viewing 5 of 10 investors. Get the full list »

Duo Oncology FAQs

  • When was Duo Oncology founded?

    Duo Oncology was founded in 2020.

  • Where is Duo Oncology headquartered?

    Duo Oncology is headquartered in Pittsburgh, PA.

  • What is the size of Duo Oncology?

    Duo Oncology has 4 total employees.

  • What industry is Duo Oncology in?

    Duo Oncology’s primary industry is Discovery Tools (Healthcare).

  • Is Duo Oncology a private or public company?

    Duo Oncology is a Private company.

  • What is the current valuation of Duo Oncology?

    The current valuation of Duo Oncology is .

  • What is Duo Oncology’s current revenue?

    The current revenue for Duo Oncology is .

  • How much funding has Duo Oncology raised over time?

    Duo Oncology has raised $12.7M.

  • Who are Duo Oncology’s investors?

    National Cancer Institute I-Corps, U.S. Department of Health and Human Services, BeiGene, Innovation Works, and NuFund Venture Group are 5 of 10 investors who have invested in Duo Oncology.

  • Who are Duo Oncology’s competitors?

    Genprex, MiNA Therapeutics, Cristal Therapeutics, CytImmune Sciences, and Innocare are some of the 47 competitors of Duo Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »